In STEP 2, researchers showed that when semaglutide was administered in combination with lifestyle intervention, there was a statistically significant greater weight loss of 9.6% achieved at 68 weeks with semaglutide 2.4 mg compared to placebo (3.4% weight loss) and 1.0 mg semaglutide (7.0% weight loss)
Publisher & Syndication Partner Liability Waiver The publisher, its editors, authors, affiliates, syndication partners, and associated content distributors assume no responsibility or liability for any loss, damage, or injury alleged to be caused-directly or indirectly-by the information presented in this article or by any product discussed
Novo said last week that CagriSema was "well-tolerated" and that the most common adverse effects were gastrointestinal, but they were "mild to moderate and diminished over time." "Investors are looking for treatment options that are best in class and will secure Novo's place in the obesity drug market," Soren Lontoft, pharma equity analyst at Sydbank, told CNBC over the phone Tuesday
~ AlphaMD For decades, men were told that testosterone feeds prostate cancer the way gasoline feeds a fire
The outcomes indicate a noteworthy impact on weight reduction and management after an intensive lifestyle intervention
IUPHAR/BPS Guide to PHARMACOLOGY
